Is ORKA stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Oruka Therapeutics Inc 10 years ago, but if you had invested on Thursday 26th of October 2023 when the price was $23.52, you would have made a loss of $-1.320 per share or -5.61%
Yes, the average daily trading liquidity for Oruka Therapeutics Inc is $1.86 million. You should therefore be able to get in and out of your positions relatively fast.
Oruka Therapeutics Inc has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Oruka Therapeutics Inc to be low [0 out of 1]